000			03792nam a22003735i 4500
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
988			_aSpringer_Medicine_2018
999			_c343838 _d343838 _x1
001			343838
003			ES-MaUEC
005			20230102120147.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			180820s2018 si | s |||| 0|eng d
020			_a9789811310744
024	7		_a10.1007/978-981-13-1074-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
050		4	_aRC827 _b2018 EB
245	1	0	_aFunctional Dyspepsia : _bEvidences in Pathophysiology and Treatment _cedited by Kazunari Tominaga, Hiroaki Kusunoki.
264		1	_aSingapore _bSpringer International Publishing _c2018
300			_a1 recurso en línea (VIII, 187 páginas) _b61 ilustraciones, 46 ilustraciones a color
490			_aMedicine (Springer-11650)
505	0		_aPART I: Etiology.-Chapter 1: Definition & Prevalence -- Chapter 2: Genetic Factor -- Chapter 3: Environmental Factors -- PART II: Pathophysiology -- Chapter 4: Neuro-gastroenterology: Central & Autonomic Nervous System.-Chapter 5: Neuro-gastroenterology: Enteric Nervous System -- Chapter 6: Neuro-gastroenterology: Esophago-gastric Function (Motility) .-Chapter 7: Neuro-Gastroenterology: Gastro-duodenal Function (Motility) and Ultrasonographic Assessment.-Chapter 8: Ghrelin and Functional Dyspepsia -- Chapter 9: Psycho-gastroenterology -- Chapter 10: Visceral Hypersensitivity Through Transient Receptor Potential Vanilloid 1 Channels (TRPV1) in Functional Dyspepsia.-PART III: Treatment.-Chapter 11: Efficacy of Acid Suppression Therapy.-Chapter 12: Prokinetics.-Chapter 13: Herbal Medicine.-PART IV: Recent Special Topics: Future Treatment Possibility -- Chapter 14: Gut Dysbiosis and Its Treatment in Patients with Functional Dyspepsia -- Chapter 15: Visceral Hypersensitivity in Functional Dyspepsia (FD) - Therapeutic Approaches to FD Based on Suppression of Visceral Hypersensitivity -- Chapter 16: Pancreatic Exocrine Function.
520			_aThe research and outcomes presented in this book gather evidence concerning both the pathogenesis and treatment of functional dyspepsia. It provides the latest information on this common non-organic disease, indicating its characteristic pathogenesis based on the brain-gut interaction and micro-environment and evidence gleaned from clinical treatment. Since the pathogenesis is associated with psychology, neurology, endocrinology and bacteriology in addition to gastroenterological physiology, it is often intractable and finding a suitable treatment rationale is challenging. Furthermore, the pathogenesis varies around the world and the efficacy of treatment using standard drugs varies among different populations worldwide; accordingly, this book highlights evidence gained in clinical trials in Japan. Functional Dyspepsia is a milestone produced by respected experts. Addressing unique topics and new findings of treatment including challenging and/or future rationales, it offers an invaluable resource for general clinicians, gastroenterologists, and basic researchers alike.
650		7	_2embne _9180402 _aEstómago _xEnfermedades
700	1		_aTominaga, Kazunari. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aKusunoki, Hiroaki. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9789811310737
776	0	8	_iPrinted edition: _z9789811310751
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-1074-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _a_alco _a_vill _b02/2019 _cm _dz _feng _ggw _h0